Adverse oral reactions associated with the COX-2 inhibitor rofecoxib
Author:
Publisher
Wiley
Subject
General Dentistry,Otorhinolaryngology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1601-0825.2004.01024.x/fullpdf
Reference23 articles.
1. Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects;Ahuja;J Pharm Pharmacol,2003
2. VICOXX Study Group. Experience of rofecoxib in patients with osteoarthritis previously treated with traditional non-steroidal anti-inflammatory drugs in Spain: results of phase 2 of the VICOXX study;Arboleya;Curr Med Res Opin,2003
3. Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial;Chang;Clin Ther,2001
4. Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial;Chang;Clin Ther,2002
5. COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy. Reports from a Symposium Held in Conjunction with the Radiation Therapy Oncology Group, June 2001 Meeting;Dicker;Am J Clin Oncol,2003
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fixed drug eruption secondary to etoricoxib;British Journal of Oral and Maxillofacial Surgery;2024-07
2. Combined treatment of dexamethasone mouthwash and low‐level laser therapy in the management of aphthous‐like ulcers caused by nonsteroidal anti‐inflammatory drugs: A case report;Clinical Case Reports;2024-03-27
3. Systemische Medikamenteneinnahme und ihr potenzieller Einfluss auf die orale Gesundheit;wissen kompakt;2023-09-11
4. Adverse Drug Events in the Oral Cavity;Dermatologic Clinics;2020-10
5. Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats;BMC Veterinary Research;2020-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3